A large study has found it makes no difference to eczema symptoms if people bathe daily or weekly. Researchers said the ...

Recommendations for optimal gestational weight gain are different depending on a woman's body mass index (BMI), ranging from ...

Educational interventions and personalized feedback may reduce inappropriate corticosteroid injections for acute respiratory infections by primary care clinicians who frequently prescribe them.

Background Guidelines strongly recommend reperfusion therapy, including thrombolysis and percutaneous coronary intervention, ...

University of Auckland researchers report that an 8-week, twice-weekly LSD microdosing regimen for major depressive disorder ...

Background Pain and fatigue are among the most debilitating symptoms of systemic sclerosis (SSc), severely impairing quality ...

Adding the PCSK9 inhibitor evolocumab to standard lipid-lowering therapy significantly reduced first major cardiovascular ...

PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies ...

Obexelimab Phase 3 INDIGO trial topline results in Immunoglobulin G4-Related Disease (IgG4-RD) expected around year-end 2025 - - Reported highly positive 12-week primary endpoint results from Phase ...

The first AI-based education intervention to undergo a rigorous clinical trial saw bigger reading gains over teacher ...

Use of rifaximin soluble solid dispersion tablets for up to 24 weeks did not increase infection-related adverse events among patients with cirrhosis, according to data presented at ACG Annual ...

WASHINGTON -- Daily treatment with the investigational oral agent HU6 reduced liver fat and body weight without muscle loss in patients with metabolic dysfunction-associated steatohepatitis (MASH), ...